Is it safe and what are the precautions for long-term use of apalutamide (Ansenko) for 20 years?

Apalutamide (Apalutamide) is a nonsteroidal androgen receptor inhibitor mainly used to treat advanced prostate cancer. There is currently insufficient clinical data to support the safety of long-term use for twenty years. Most clinical trials have an observation period of several years, and long-term follow-up data are limited, so there is still uncertainty about the safety of continued medication for twenty years. Long-term use may accumulate drug toxicity and have potential effects on liver, cardiovascular system and bone health, which requires special attention.

During long-term medication, the most common side effects include fatigue, rash, increased blood pressure, and thyroid dysfunction. If patients continue to use it for many years, they need to undergo regular hematology, liver function and thyroid function tests so that abnormalities can be detected and intervened in a timely manner. In addition, long-term androgen receptor inhibition may increase the risk of osteoporosis. It is recommended that patients pay attention to bone density during long-term treatment, and supplement calcium, vitamin D or use anti-osteoporosis drugs in conjunction with doctor's recommendations.

In terms of long-term medication management, patients should strictly follow the doctor's prescription and should not stop taking medication on their own or adjust the dosage at will. If serious side effects occur, such as cardiovascular events, severe rash or obvious abnormalities in liver function, you should contact your doctor promptly for treatment. If necessary, adjust the dose or consider short-term discontinuation of the drug. Regular follow-up and comprehensive evaluation are key to ensuring long-term safe use.

In addition, long-term medication also requires attention to drug interaction issues. The metabolism of apalutamide may affect the plasma concentrations of other drugs, especially anticoagulants, antihypertensive drugs and cardiovascular drugs. Patients should inform their attending physician of all medications they are taking and adjust their medication regimen under the guidance of their physician to reduce potential risks. In short, long-term use of apalutamide requires strict monitoring, individualized management, and scientific medication under the guidance of a doctor to ensure medication safety to the greatest extent.

Reference materials:https://www.drugs.com/